Kallikrein-14

BE0020746ProteinHumansKLK14

Serine-type endopeptidase with a dual trypsin-like and chymotrypsin-like substrate specificity. It is acted on by 1 drug in DrugBank.

Gene name
KLK14
UniProtKB entry
Q9P0G3Swiss-Prot
Cellular location
Secreted, extracellular space
Residues / weight
251 residues · 27,452 Da
Also known as
3.4.21.- · hK14 · Kallikrein-like protein 6 · KLK-L6 · KLKL6

Resolves to

Protein
UniProtQ9P0G3UniProt nameKLK14_HUMAN
Gene
HGNCHGNC:6362NCBI Gene43847GeneCardsKLK14
Pharmacology
IUPHAR/GtoPdb2866KEGGhsa:43847
Drugs

What you can answer from here — as of September 03, 2024

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
10GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which compounds in development act on Kallikrein-14, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In